It seems likely that topics for today's prepared remarks will include the just-announced JV in Brazil, and the FDA approval of Zioptan™, for glaucoma. What else will Peter Kellogg discuss? Probably nothing new and material, but you might want to tune in at 11 a.m. Eastern, to be sure (you'll need to leave a working e-mail address, and a name to do so):
. . . .Merck, known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, Merck's chief financial officer is scheduled to present at the Leerink Swann 2012 Global Healthcare Conference in New York City on Feb. 15, at 11:00 a.m. EST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation. . . .
I'll catch the replay, as I am busy at that time, but will post anything significant. It would seem unlikely there would be such a development, unless he decides to describe the terms of the Cobb v. Merck settlement.